[Combined radiotherapy and endovascular x-ray therapy for invasive cancer of the urinary bladder]
/in Dendritic Cells, International Publications, Urothelial CarcinomaAllogeneic dendritic cell vaccination against metastatic renal cell carcinoma with or without cyclophosphamide
/in Hypernephroma, International PublicationsPhase II study of carboplatin and whole body hyperthermia (WBH) in recurrent and metastatic cervical cancer
/in Cervical Cancer, International PublicationsDendritic cell based vaccines: progress in immunotherapy studies for prostate cancer
/in International Publications, Prostate CancerImmunoregulation of dendritic and T cells by alpha-fetoprotein in patients with hepatocellular carcinoma
/in Hepatocellular Carcinoma, International PublicationsTherapeutic dendritic-cell vaccine for chronic HIV-1 infection
/in HIV/AIDS, International PublicationsVaccination of glioma patients with fusions of dendritic and glioma cells and recombinant human interleukin 12
/in Dendritic Cells, Glioblastoma, International PublicationsSurgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study
/in Dendritic Cells, Glioblastoma, International Publications, IOZK Veröffentlichungen
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer